tag toxic-positivity 
The Pharma Data
OCTOBER 21, 2020
21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. But even with TKIs available, patients with Ph-positive ALL still undergo intensive chemotherapy — and it takes a toll. WEDNESDAY, Oct.
The Pharma Data
OCTOBER 21, 2020
21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. But even with TKIs available, patients with Ph-positive ALL still undergo intensive chemotherapy — and it takes a toll. WEDNESDAY, Oct.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
AUGUST 17, 2020
With several biologics in the pipeline, including one in early stage clinical trials for head and neck cancer, the company is positioned to engineer highly specific biologics against immune targets in the body. Cell-Based Immunotherapy vs. Immune Biologics. Immunotherapy involves leveraging components of the immune system (i.e.
Drug Discovery World
NOVEMBER 13, 2023
Felix Unverdorben, PhD, Associate Director, Immatics Biotechnologies, on: ‘TCER: Next-generation, half-life extended TCR bispecifics designed to maximise efficacy while minimising toxicities for patients’. Jeremy Fry, Dr, Director of Sales, ProImmune, on: ‘Mastering immunogenicity and biologics development’.
XTalks
FEBRUARY 11, 2021
At around the same time, in 1953, Franklin decided to leave King’s College as she was not happy working in the toxic environment, ultimately abandoning her DNA work at the college. She did write up three manuscripts on her findings before leaving.
Expert insights. Personalized for you.
52 
Let's personalize your content